C1 esterase inhibitor recombinant Intravenous and Doxorubicin liposomal
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Doxorubicin liposomal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: doxorubicin liposomal
Brand name: Doxil, Lipodox, Lipodox 50
Synonyms: DOXOrubicin (Liposomal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Doxorubicin liposome Intravenous
- C1 esterase inhibitor recombinant Intravenous-Doxy 100
- C1 esterase inhibitor recombinant Intravenous-Doxycycline
- C1 esterase inhibitor recombinant Intravenous-Doxycycline Calcium
- C1 esterase inhibitor recombinant Intravenous-Doxycycline Capsules (Rosacea)
- C1 esterase inhibitor recombinant Intravenous-Doxycycline Capsules with Omega-3 and Vitamin E Capsules
- Doxorubicin liposomal-C1 esterase inhibitor, human Intravenous
- Doxorubicin liposomal-C1 Inhibitor (Human)
- Doxorubicin liposomal-C1 Inhibitor (Human) (Berinert)
- Doxorubicin liposomal-C1 Inhibitor (Human) (Cinryze)
- Doxorubicin liposomal-C1 Inhibitor (Human) (Haegarda)
- Doxorubicin liposomal-C1 Inhibitor (Recombinant)